Simplified Chinese
26
2019-04
On the afternoon of April 26, 2019, a delegation led by Zhai Lixin, Director of the Zhongguancun Administrative Committee of Beijing, accompanied by He Rui, Member of the Standing Committee of the Daxing District CPC Committee and Deputy District Mayor, and Tian Dexiang, Secretary of the Party Working Committee of the Daxing District Biomedical Base, paid a visit to Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as Minhai Bio). The company’s General Manager Zheng Haifa, Executive Deputy General Manager Liu Jiankai, Deputy General Manager Xiao Qiyu, and other relevant leaders joined the delegation on the inspection tour.
24
2019-04
A 2016 study showed that for every dollar invested in childhood vaccination, the return on investment reaches $44—far exceeding the 1:3 return from infrastructure development. Today, China has become the world’s largest vaccine producer and reaps substantial benefits from immunization; however, according to a WHO report, one in ten newborns worldwide still remains unvaccinated. Consequently, as Chinese-made vaccines expand into international markets, they not only contribute to global health security but also further enhance China’s image as a responsible major country. On December 27 last year, Pakistan’s Forum Express…
24
2019-04
Minhai Biotechnology was honored by the General Union of the Biopharmaceutical Industrial Base.
On the afternoon of April 11, the General Union of the Pharmaceutical Industrial Base convened the 2019 Annual Conference of Grassroots Union Chairpersons in the park. Nearly one hundred union chairpersons and union officials from more than 60 enterprises that have established unions attended, jointly reviewing the union’s work in 2018 and discussing plans for 2019.
11
2019-04
On the morning of April 8, members of the Hermansen family, along with senior executives from DSD Group and HerfoFinans of the Hefu Financial Group, paid a site visit to Beijing Minhai Biotechnology Co., Ltd. Su Rong, Director of the District Science and Technology Commission; Ma Yanzhu, Director of the District Industrial Promotion Center; and Tian Dexiang, Director of the Biopharmaceutical Base Management Committee, accompanied the delegation. Zheng Haifa, General Manager of Minhai Biotechnology, Wu Chengyu, Assistant to the General Manager, Zhang Qian, Manager of the International Cooperation Department, and other relevant leaders extended a warm welcome to the visiting delegation on behalf of Minhai Biotechnology.
29
2019-03
IKSA experts visited Minhai Biotechnology to assess the operation of its quality management system.
From March 18 to 22, 2019, a three-member IKSA expert team visited Minhai to assess the operation of its quality management system. Minhai’s General Manager Zheng Haifa, Executive Deputy General Manager Liu Jiankai, Vice President of Quality Li Xiangqun, Vice President of Production Nie Xiaoqi, and other relevant department heads extended a warm welcome to the IKSA experts.